Juan Carlos Garcia Pagan

, Spain

Juan Carlos García Pagán: MD, PhD, Prof


Chair - Meet the Experts: Portosinusoidal vascular disease: what is there behind this new name? 14 April 2019 08:30 - 09:20
Meet the Experts
More ...
Chair - Parallel session: Portal Hypertension - Refining risk stratification and therapy 11 April 2019 16:00 - 18:00
More ...
Chair - Skills in hepatology: Vascular liver disease board 10 April 2019 10:00 - 11:00
Skills in Hepatology
More ...


Prevention of variceal bleeding and medical management of acute variceal bleeding 10 April 2019 14:05 - 14:20
Factors predicting survival in patients with high-risk acute variceal bleeding treated with pre-emptive (Early)-TIPS 11 April 2019 17:30 - 17:45
Case presentation 10 April 2019 10:00 - 10:00


Role of next generation sequencing in the etiological diagnosis of splanchnic venous thrombosis Rare liver diseases (including pediatric and genetic) More
Anti-VHC therapy does not increase de risk of developing splanchnic vein thrombosis in patients with cirrhosis Viral Hepatitis C: Post SVR and long term follow up More
Factor V and VIII may predict the risk of recurrent splanchnic thrombosis in patients with non-cirrhotic chronic portal vein thrombosis of local and idiopathic etiology not receiving anticoagulation Rare liver diseases (including pediatric and genetic) More